Midtrimester abortion.
D000019:Abortifacient Agents / Q000008:administration & dosage; D000028:Abortion, Induced / Q000009:adverse effects / Q000379:methods*; D001291:Attitude of Health Personnel; D002404:Catheterization; D003475:Curettage / Q000295:instrumentation; D004106:Dilatation / Q000295:instrumentation; D015232:Dinoprostone; D004865:Equipment and Supplies, Hospital; D005113:Extraction, Obstetrical; D005260:Female; D006801:Humans; D006982:Hypertonic Solutions; D007431:Intraoperative Complications; D007795:Laminaria; D009772:Obstetrical Forceps; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011458:Prostaglandins E / Q000008:administration & dosage; D012462:Saline Solution, Hypertonic
D000019:Abortifacient Agents; D006982:Hypertonic Solutions; D011458:Prostaglandins E; D012462:Saline Solution, Hypertonic; D015232:Dinoprostone